iCAD ProFound AI Introduction

The implementation of ProFound AI offers numerous benefits to radiologists, healthcare facilities, and patients. It significantly improves cancer detection rates, with studies showing up to a 27% increase in cancer detection per 1000 patients. The platform enhances radiologist performance by reducing reading time by up to 52.7%, improving sensitivity by 8%, and decreasing false positives and unnecessary recalls by 7.2%. This not only increases efficiency but also reduces patient stress and healthcare costs associated with false positives. The risk assessment feature allows for more personalized screening plans, potentially catching cancers earlier in high-risk patients. Overall, ProFound AI empowers healthcare providers to deliver more accurate, efficient, and personalized breast cancer screening and diagnosis, ultimately leading to improved patient outcomes and potentially saving more lives.